All posts tagged
Which EU Immuno-Oncology Company are you Cheering for?
UPDATE: Novartis broadens CAR-T onslaught with FDA endorsement
Meet One of the Most Successful German Biotech Leaders Ever
The Most Important Battle in Gene Editing: CRISPR versus TALEN
Heptares Takes Home €11M for its Next-Generation Checkpoint Inhibitor
Immuno-oncology is Overcrowded – Here is Where Startups Can Succeed
“In the Coming Decade, Off-the-Shelf Cell Therapy will Become a Reality”
A Cure for Cancer? How CAR-T Therapy is Revolutionizing Oncology
More News! Smart Lens looks More Distant & a Pollen Allergy Cure?
More News! Is CRISPR better than TALEN for CAR-T?
The English Countryside brings Innovation in Immuno-Oncology
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
Labiotech UG, All Rights Reserved -
Send this to friend